Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Long-term hormone therapy does more harm than good for men with low PSAs after prostate surgery

A secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer finds long-term hormone therapy does more harm than good for many men and calls for rethinking treatment guidelines based on a patient's post-operative prostate-specific antigen (PSA) level.

26 Sep 2019

Study shows miRNAs in semen as non-invasive biomarkers for prostate cancer

Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute, led by Dr. Sara Larriba, in collaboration with Dr. Francesc Vigués and Dr. Manel Castells of the Urology Service of Bellvitge University Hospital, show the usefulness of certain molecules, the miRNAs in semen, as non-invasive biomarkers for prostate cancer.

26 Sep 2019

Prostate cancer risk linked to assisted reproduction techniques

A study published in BMJ has revealed a link between the risk of prostate cancer and men who have become fathers via assisted reproduction techniques.

26 Sep 2019

Study explores link between assisted reproduction and prostate cancer risk

In a new national register study from Lund University in Sweden, researchers have studied the link between prostate cancer and infertility. The study, published in the British Medical Journal, includes over one million Swedish men.

26 Sep 2019

Reactivating ‘tumor suppressor’ genes could offer new therapeutic approach for cancer

Scientists have developed a method which is able to switch ‘tumor suppressor’ genes back on after they have been silenced by cancer cells.

25 Sep 2019

Men with prostate cancer want access to female doctors

Malecare, America’s largest men’s cancer support network, this week announced the world’s first prostate cancer patient conference to feature an all-female faculty featuring twelve of the U.S.A.’s top prostate cancer clinicians

25 Sep 2019

New genetic test could help avoid unnecessary prostate cancer surgery

Men who develop prostate cancer could avoid having unnecessary surgery or radiotherapy thanks to a new, more precise genetic test which is being trialed in Leeds.

25 Sep 2019

Bath researchers identify promising prostate cancer drug candidates

Cancer researchers from the University of Bath have identified some promising drug candidates by using high-throughput screening methods to test tens of thousands of molecules.

24 Sep 2019

Survey: Men have low levels of awareness about prostate health and function

The survey, which assessed knowledge of the prostate in 3,010 men over 50 years in the UK, Germany and France, found that just one in 4 men (26%) over the age of 50 are correctly able to identify the prostate's main function.

24 Sep 2019

Non-viral gene delivery method more effective and safer than standard viral approaches

The non-viral, bio-inspired gene delivery method developed by researchers at RMIT University has proven effective in laboratory tests and is safer than standard viral approaches.

24 Sep 2019

Discovery provides potential therapeutic target for prostate cancers with PTEN mutation

PTEN, a tumor suppressor gene mutated in approximately 20% of primary prostate cancers, and in as many as 50% of androgen deprivation-resistant prostate cancers, relies on another gene, ARID4B, to function.

24 Sep 2019

Transperineal prostate biopsy minimizes risk of infection, may increase detection rate

Loyola Medicine is among the first centers to offer a new minimally invasive prostate biopsy that minimizes the risk of infection and may increase the cancer detection rate.

24 Sep 2019

U-M and Karmanos receive NCI grant to find new solutions for prostate cancer

Michigan's two elite cancer programs are joining forces to find new solutions for prostate cancer. The University of Michigan Rogel Cancer and the Barbara Ann Karmanos Cancer Institute have received a prestigious $9.2 million grant from the National Cancer Institute.

23 Sep 2019

UCSF launches new initiative to accelerate prostate cancer research

UC San Francisco announced Thursday it will establish the UCSF Benioff Initiative for Prostate Cancer Research, made possible by a $35 million gift from Marc and Lynne Benioff.

23 Sep 2019

New clinical trial tests immunotherapy drug for prostate cancer patients on active surveillance

Stephenson Cancer Center Testing Drug for Prostate Cancer Patients on Active Surveillance OKLAHOMA CITY - Men who are diagnosed with low-risk prostate cancer usually opt for active surveillance - a monitoring of their cancer over time without undergoing treatments that would cause side effects.

20 Sep 2019

Scientists identify new family of drugs which could combat prostate cancer

A new family of drugs which inhibit the activity of a protein associated with prostate and other cancers has been reported by scientists from the University of Bath.

20 Sep 2019

Mitochondrial fission factor could represent a promising target for cancer therapy

Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types.

20 Sep 2019

Roswell Park moving three-pronged immunotherapy strategy forward with support from DoD grant

A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a U.S. Department of Defense grant to Pawel Kalinski, MD, PhD, Vice Chair for Translational Research and Rustum Family Professor for Molecular Therapeutics and Translational Research at the Buffalo, N.Y.-based cancer center.

18 Sep 2019

Men with prostate cancer can have healthy sex lives after surgery

There's a perception that surgery to treat prostate cancer will spell the end of a man's sex life.

17 Sep 2019

Pre-SRT PSA could serve as prognostic and predictive biomarker of benefit from hormone therapy

Initial results of NRG Oncology Clinical Trial RTOG 9601 in men with biochemically recurrent prostate cancer receiving salvage radiotherapy demonstrated improvement in OS from the addition of long-term hormone therapy to SRT.

17 Sep 2019

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Long-term hormone therapy does more harm than good for men with low PSAs after prostate surgery

Study shows miRNAs in semen as non-invasive biomarkers for prostate cancer

Prostate cancer risk linked to assisted reproduction techniques

Study explores link between assisted reproduction and prostate cancer risk

Reactivating ‘tumor suppressor’ genes could offer new therapeutic approach for cancer

Men with prostate cancer want access to female doctors

New genetic test could help avoid unnecessary prostate cancer surgery

Bath researchers identify promising prostate cancer drug candidates

Survey: Men have low levels of awareness about prostate health and function

Non-viral gene delivery method more effective and safer than standard viral approaches

Discovery provides potential therapeutic target for prostate cancers with PTEN mutation

Transperineal prostate biopsy minimizes risk of infection, may increase detection rate

U-M and Karmanos receive NCI grant to find new solutions for prostate cancer

UCSF launches new initiative to accelerate prostate cancer research

New clinical trial tests immunotherapy drug for prostate cancer patients on active surveillance

Scientists identify new family of drugs which could combat prostate cancer

Mitochondrial fission factor could represent a promising target for cancer therapy

Roswell Park moving three-pronged immunotherapy strategy forward with support from DoD grant

Men with prostate cancer can have healthy sex lives after surgery

Pre-SRT PSA could serve as prognostic and predictive biomarker of benefit from hormone therapy

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in